S 5326: Health Care Fraud Prevention and Enforcement Act

S 5326 in plain English: This bill would increase federal funding for health care fraud prevention and enforcement programs starting in fiscal year 2027, with funding levels rising each year through 2029 and beyond. It sets specific annual appropriations across multiple fraud-fighting programs within Medicare and Medicaid. The bill was introduced by Sen. Cortez Masto and referred to the Senate Finance Committee.

Stated purpose

To strengthen oversight and enforcement of the Health Care Fraud and Abuse Control Program by increasing funding for anti-fraud activities in Medicare and Medicaid and expanding the investigative authority of the Department of Health and Human Services Inspector General.

Key points

• Provides $1,280,000,000 for fiscal year 2027, rising to $1,480,000,000 by fiscal year 2029 for one major fraud enforcement funding stream
• Allocates $490,000,000 in fiscal year 2027, increasing to $570,000,000 in fiscal year 2029 under a separate funding category
• Sets $320,000,000 for fiscal year 2027, growing to $370,000,000 in fiscal year 2029 under another program component
• Provides $230,000,000 in fiscal year 2027, rising to $270,000,000 in fiscal year 2029 under an additional funding stream
• Allocates $110,000,000 for fiscal year 2027, increasing to $130,000,000 by fiscal year 2029 for another enforcement category

Arguments supporters make

• Health care fraud costs taxpayers and Medicare billions of dollars each year, and increasing enforcement funding is a proven way to recover more money than it costs — returning savings to the program.
• Expanding the Inspector General's authority to cover ACA-related programs closes a gap that fraudsters could exploit, making oversight more comprehensive.
• The bill has bipartisan support, showing that cracking down on waste, fraud, and abuse is a shared priority regardless of party.

Arguments opponents make

• Raising enforcement budgets by hundreds of millions of dollars increases federal spending, and critics may question whether the return on investment justifies the cost, especially if fraud estimates are overstated.
• Expanding investigative authority to ACA programs could subject more legitimate providers to audits and administrative burdens, potentially discouraging participation in those programs.
• Automatic, inflation-linked funding increases written into law reduce congressional flexibility to adjust spending based on future priorities or fiscal conditions.

Tradeoffs

Spending more on fraud enforcement may recover money and deter abuse, but it also increases federal outlays and the scope of government oversight over health care providers — balancing potential savings against added costs and regulatory burden.

Current status in Congress: In committee.

NewsClear — neutral news & congressional tracking · Bill of the Week